No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Bevacizumab / therapeutic use
-
Cost-Benefit Analysis
-
Diabetic Retinopathy / diagnostic imaging
-
Diabetic Retinopathy / drug therapy*
-
Diabetic Retinopathy / physiopathology
-
Fovea Centralis
-
Humans
-
Intravitreal Injections
-
Macular Edema / diagnostic imaging
-
Macular Edema / drug therapy*
-
Macular Edema / physiopathology
-
Ranibizumab / therapeutic use
-
Retinal Detachment / diagnostic imaging
-
Retinal Detachment / drug therapy*
-
Retinal Detachment / physiopathology
-
Retrospective Studies
-
Tomography, Optical Coherence
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / physiology
Substances
-
Angiogenesis Inhibitors
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Ranibizumab